Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,456 active trials24 approved drugs58 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,550 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00485303 | An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | completed | Phase 2 | 58 | Cougar Biotechnology, Inc.INDUSTRY | 2 | Jul 2, 2013 | clinicaltrials |
| NCT00003104 | Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 |
| NCT00003367 | Diet and PSA Levels in Patients With Prostate Cancer | completed | Phase 3 | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00006078 | Lycopene In Preventing of Prostate Cancer | completed | Phase 1 | — | University of Illinois at ChicagoOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00082927 | Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain | completed | Phase 3 | 580 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00093561 | Lycopene in Preventing Prostate Cancer in Healthy Participants | completed | Phase 1 | — | University of Illinois at ChicagoOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00255606 | Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer | completed | Phase 3 | 360 | Tampere UniversityOTHER | 3 | Jun 26, 2013 | clinicaltrials |
| NCT00316927 | Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | completed | Phase 3 | 260 | St. Bartholomew's HospitalOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00416325 | Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer | completed | Phase 1 | 18 | University of Illinois at ChicagoOTHER | 0 | Jun 26, 2013 | clinicaltrials |
| NCT00002480 | Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00002637 | Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003394 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | completed | Phase 1 / Phase 2 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00006019 | Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00012142 | CCI-779 in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00016393 | BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00025194 | Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00078910 | Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer | completed | Phase 2 | 130 | National Cancer Institute (NCI)NIH | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00992186 | A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer | completed | Phase 2 | 46 | Centocor Research & Development, Inc.INDUSTRY | 4 | Jun 24, 2013 | clinicaltrials |
| NCT00003740 | Trastuzumab in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00537381 | An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer | completed | Phase 2 | 131 | Centocor, Inc.INDUSTRY | 10 | Jun 20, 2013 | clinicaltrials |
| NCT00004928 | Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005634 | Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00045227 | Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00045331 | Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer | completed | N/A | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00060437 | Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00956904 | Ultrasound-Guided Navigation in Robot-Assisted Laparoscopic Radical Prostatectomy | terminated | Early Phase 1 | 50 | Johns Hopkins UniversityOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00006380 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00024232 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00433602 | Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors | completed | — | 64 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jun 12, 2013 | clinicaltrials |
| NCT01228760 | A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer | completed | Phase 1 | 46 | Astellas Pharma IncINDUSTRY | 1 | Jun 7, 2013 | clinicaltrials |
| NCT00016107 | Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00039104 | Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00061867 | Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | ImunonINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT00662324 | Development of a Clinical Trial Specific Question Prompt List | completed | — | 67 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00558272 | Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease | completed | Phase 2 | 139 | AstraZenecaINDUSTRY | 8 | May 27, 2013 | clinicaltrials |
| NCT01218243 | An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia | completed | Phase 2 | 100 | Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | May 27, 2013 | clinicaltrials |
| NCT00608920 | Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping(SPECT) | completed | N/A | 15 | Washington University School of MedicineOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT01733836 | Prostate Cancer Active Surveillance Metformin Trial | withdrawn | Phase 2 | 0 | University Health Network, TorontoOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT00182052 | Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer | completed | Phase 3 | 100 | Massachusetts General HospitalOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT00710658 | Internet Support for Cancer Patients(WebChoice) | completed | N/A | 325 | Oslo University HospitalOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01215513 | Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients | completed | Phase 3 | 127 | Ferring PharmaceuticalsINDUSTRY | 1 | May 22, 2013 | clinicaltrials |
| NCT00077402 | Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer | completed | Phase 2 | 50 | Cancer Therapeutics Research GroupOTHER | 3 | May 15, 2013 | clinicaltrials |
| NCT00087347 | Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer | completed | — | 14 | Massachusetts General HospitalOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT00381173 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | completed | Phase 1 | 22 | Eisai Inc.INDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT00702104 | Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area | completed | — | — | University of California, San FranciscoOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT00136526 | Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer | completed | Phase 2 | 30 | University of WashingtonOTHER | 0 | May 9, 2013 | clinicaltrials |
| NCT00095667 | Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | May 8, 2013 | clinicaltrials |
| NCT01826565 | Comparison of Two Insertion Technique of I-gel(I-gel90) | unknown | N/A | 100 | Seoul National University HospitalOTHER | 0 | May 6, 2013 | clinicaltrials |
| NCT00005073 | Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms | terminated | Phase 3 | 544 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Jul 2, 2013source: clinicaltrials